A major breakthrough in cancer investigation is occurring with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently lost in various forms of malignancies, https://bookmarksusa.com/story22034588/mini-antibodies-reactivate-p53-new-potential-pathway-for-tumor-therapy